ArticleHealth & justice2017
Trends in drug offers among adolescents in the United States, 2002-2014.
Article in Health & justice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Margin for error: examining racial and ethnic trends in adolescent risk propensity.Social psychiatry and psychiatric epidemiology · 2021Article
- Commentary on Burdzovic Andreas & Bretteville-Jensen (2017): Cannabis use opportunities-an under-researched factor in substance use epidemiology.Addiction (Abingdon, England) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundBeing offered illicit drugs is a critical factor leading to drug initiation and other psychosocial risk behaviors among adolescents in the United States. However, there exist few studies examining the recent trends in drug offers among adolescents, particularly across racial/ethnic subgroups. The present study examines trends and psychosocial/behavioral correlates of drug offers among adolescents of the three largest racial/ethnic groups.
methodsWe used data from the 2002-2014 National Survey on Drug Use and Health of adolescents aged 12-17, which include African-American, Hispanic, and White adolescents (n = 199,700) in the U.S. We estimated the prevalence of past-month drug offers by race/ethnicity, and conducted logistic regression analyses to test the significance of the trends and to examine the correlates of drug offers.
resultsOverall, the prevalence of drug offers decreased significantly from 16.3% in 2002 to 12.3% in 2014, reflecting a 24.5% reduction in the relative proportion of adolescents who were offered drugs. While the decreasing trends were observed in all subgroups (e.g., race/ethnicity), the decreases were more limited among African-American and Hispanic youth than White youth. As a result, while no differences were observed at the outset of the study, a higher proportion of African-American and Hispanic adolescents were offered drugs between 2012 and 2014.
conclusionsFindings suggest a general decline in drug offers among adolescents in the U.S., but racial/ethnic differences in prevalence were identified. This underscores the importance of further efforts to understand the racial/ethnic differences in drug offers and suggests the need for culturally-sensitive drug prevention programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.